Nangona ngokuqhelekileyo kuthiwa "yi-barium," isisombululo esisetyenziselwa iimvavanyo zonyango empeleni asenziwe nge-barium yodwa. Ubungqina beBarumum yinto efunyanwa ngokudibanisa namanye amacandelo ngenxa yokuba iphendukela emoyeni, kwaye ngoko kufuneka ikhutshwe kwaye ikhutshwe, ngokuqhelekileyo isuka kwi-mineral barite. Igama elithi barium lisuka kwigama lesiGrike elisindayo, "i-barys". Ngaphandle kwezicelo zonyango, i-barium ineendlela ezahlukahlukeneyo kumashishini okuvelisa kunye nokuloba kunye neyongeziweyo kwimitshini yomlilo eyenza imibala eluhlaza.
Barium Sulfate
Isisombululo se-barium esetyenziswa kwiimvavanyo ze-radiological ngokuqhelekileyo zibizwa ngokuba ngamagama aquka "umxube ohlukeneyo," "i-barium enema," "i-barium swallow", "idlo ye-barium" okanye "i-salum ye-salum". Le nto yenziwe yi-barium sulfate (i-BaSO4), ipowder eneendawo ezikhethekileyo ezenza kube luncedo kwimifanekiso yokucinga. Kubaqalayo, i-barium sulfate isinyithi, i-chalky, kwaye ayiyi kuchithwa emanzini, leyo yipropati ebangela ukuba idlule emzimbeni ngaphandle kokuxutywa. Okwesibini, i-barium sulfate inzima kwaye isasaza i- x-ray , oko kuthetha ukuba inokubonisa ukungafani nefilimu ye-x kunye ne-radiologist ukubona izakhiwo zangaphakathi. I-barium iya kubonakala ingumhlophe kwi-x ray, eyenza kube lula ukubona izitho ezinjengomathumbu omncinci, intumbu enkulu , isisu, kunye ne-rectum.
I-Barium sulfate exiliswe ngokuqhelekileyo iqhutywe ngamanzi kwaye inikwe i-flavoring ukwenzela ukuba kube lula ukuba izigulisi ziphuze.
Ngamanye amaxesha isiphuzo se-carbonate sinikwe kunye ne-barium contrast, okanye ukuhluka kwe-barium kuya kuba ne-carbonation. Umoya uza kubonakala mnyama kwifilimu ye-ray, unikezela ngokungafani ngakumbi nomhlophe oya kuba ngumphumo weengubo zeBarum ngaphakathi kwendlela yokugaya. Oku kubizwa ngokuphindaphinda kabini .
I-sulfate ye-Barium esetyenziselwa ukuvavanya i-digestive tract tests ifakwe kwi-rectum ngokusebenzisa i-tube. Umoya unako ukongezwa ngethubhu, ngamanye amaxesha emva kokuba i-barium igxothwe, ukuze i-radiologist ibe nombono omuhle wekholoni.
Uvavanyo olusebenzisa i-Barium
Isisombululo se-barium sisetyenziswe kwiimvavanyo ezahlukahlukeneyo ze-radiological, kubandakanya ezininzi ukuba abantu abanezifo zesibindi sokuvuvukala (IBD) bangangena njengenxalenye yokuxilongwa kwabo kunye neyeza. Ezinye zezi mvavanyo ziquka:
- I-Barium enema : Olu vavanyo, olubizwa ngokuba luchungechunge oluphantsi lwesisu, luluhlu lwe-x-ray eyenziwa emva kokuba isiguli sifumane i-enema ye-sulfate ye-sulfate.
- Ingqungquthela yeBarum : Ebizwa ngokuba yichungechunge eliphezulu lwesisu, olu vavanyo lwenziwa emva kokusela isisombululo se-barium. I-ray-ray ithathwa kwiphepha eliphezulu lokugaya njengoko i-barium sulfate ihamba.
I-Barium Toxicity
Iimvavanyo ze-radiological usebenzisa i-barium sulfate zikhuselekile kakhulu. Xa isetyenziselwa kakuhle inkqubo, i-barium ayinakunyulwa ngumzimba kunye nobutyhefu ayiyona nto ixhalabisa ngayo. Nangona kunjalo, kubalulekile ukuba i-sulfate ye-barium isuswe kumzimba ekupheleni kovavanyo. Ukuba uye waba novavanyo usebenzisa i-barium, ugqirha uya kukunika imiyalelo emva kokuvavanya.
Abanye abantu banokuba nezikhundla ezimhlophe emva kokuvavanya ngokusebenzisa i-barium sulfate. Nayiphi na imiqondiso engafanelekileyo okanye iimpawu emva kokuvavanywa, njengentlungu yesisu, ukumbathisa , okanye izithambiso ezincinci, kufuneka zixelelwe ngugqirha wakho.
I-Barium esetyenziselwa ezinye iinjongo, ezifana nemisebenzi yokuqhumisa umlilo, akufanele nanini isongwe ngenxa yokuba inetyhefu. Iimpawu kunye neempawu zesetyhefu ye-barium zingaquka:
- Ukungasebenzi kwamathambo
- Igazi elonyukayo
- Intliziyo engavumelekanga
- Ukuguqulwa kwamathambo
- Ukukhubazeka
- Ukungaphumeleli kokuphefumula
Imithombo:
Amaziko okuLawula nokuKhuselwa kwezifo (CDC). "I-Barium inetyity emva kokuchazwa kwesisombululo esingafaniyo-iGoias State, eBrazil, ngo-2003." I-MMWR I-Morb I-Dead Death Rep. 2003 ngo-Oktobha 31; 52 (43): 1047-1048.
I-Rhyee SH, i-Heard K. "I-balmum enobuqhetseba obunobungozi bokungena" inyoka "yomlilo." J Med Toxicol. 2009 Dec; 5 (4): 209-213.